Bicaudal D2 (BICD2) encodes a highly conserved motor adaptor protein that regulates the dynein-dynactin complex in different cellular processes. Heterozygous mutations in BICD2 cause autosomal dominant lower extremity-predominant spinal muscular atrophy-2 (SMALED2). Although, various BICD2 mutations have been shown to alter interactions with different binding partners or the integrity of the Golgi apparatus, the specific pathological effects of BICD2 mutations underlying SMALED2 remain elusive. Here, we show that the fibroblasts derived from individuals with SMALED2 exhibit stable microtubules. Importantly, this effect was observed regardless of where the BICD2 mutation is located, which unifies the most likely cellular mechanism affecting microtubules. Significantly, overexpression of SMALED2-causing BICD2 mutations in the diseaserelevant cell type, motor neurons, also results in an increased microtubule stability which is accompanied by axonal aberrations such as collateral branching and overgrowth. To study the pathological consequences of BICD2 mutations in vivo, and to address the controversial debate whether two of these mutations are neuron or muscle specific, we generated the first Drosophila model of SMALED2. Strikingly, neuron-specific expression of BICD2 mutants resulted in reduced neuromuscular junction size in larvae and impaired locomotion of adult flies. In contrast, expressing BICD2 mutations in muscles had no obvious effect on motor function, supporting a primarily neurological etiology of the disease. Thus, our findings contribute to the better understanding of SMALED2 pathology by providing evidence for a common pathomechanism of BICD2 mutations that increase microtubule stability in motor neurons leading to increased axonal branching and to impaired neuromuscular junction development.
Introduction
Variants in BICD2 (Bicaudal D2; MIM*609797) cause SMALED2 (autosomal dominant lower extremity-predominant spinal muscular atrophy 2; MIM no. 615290). SMALED2 is characterized by muscle weakness and atrophy predominantly of the lower limbs, although in some cases the upper limbs may also be affected. In the majority of the cases, symptoms are congenital or appear in early childhood, but few cases with adult onset have also been described. Individuals with SMALED2 present difficulties in walking, specifically they show waddling gait; they are able to walk on toes but not on heels. The course of the disease is non-or slowly progressive (1) (2) (3) (4) .
BICD2 is highly conserved among metazoans. While heterozygous loss of Bicd2 in mouse and the sole BicD gene in Drosophila melanogaster is not pathological, the complete absence results in lethality during early fly development and in early post-natal life in mice (5, 6) . All SMALED2-causing BICD2 variants are heterozygous missense and are considered to exert a gain of function effect (7) .
BICD2 is a multifunctional adaptor for microtubule motor proteins, including the minus end-directed dynein-dynactin complex and the plus end-directed kinesin-1 kinesin family member 5A (8) (9) (10) (11) (12) . Adaptor proteins mediate the specific binding between the motor protein and its cargo. In this manner, adaptors regulate the function and localization of the motor protein (10) . Motor proteins have important functions not only in microtubule-mediated transport but also in regulating microtubule polymerization dynamics, and microtubule length (13, 14) . Defects in motor transport and microtubule dynamics have been associated with alterations in neuronal morphology and neurodegenerative disorders (15) (16) (17) (18) (19) (20) .
Experimental evidence has been provided to understand the consequences of BICD2 mutations on a cellular and molecular level. Various BICD2 mutations impair the interactions with its binding partners, dynein-dynactin and the cargo Ras-associated protein RAB6A (1, 2) . Additionally, in vitro studies showed that certain BICD2 mutations cause Golgi fragmentation (1, 4, 7) . Despite the involvement of BICD2 in different cellular processes, all of the SMALED2-causing BICD2 mutations affect lower motor neurons (1, 2, 4) . However, the specific impact of BICD2 mutations on motor neurons is not yet completely understood. It also remains unclear whether different SMALED2-causing BICD2 mutations share a common pathological mechanism. Here we performed functional studies of these mutations to gain further insights into the pathological consequences of SMALED2-causing BICD2 mutations.
Because BICD2 mutations alter interactions with the microtubule-transport machinery (dynein-dynactin complex), we hypothesized that the BICD2 mutations may impact microtubules. Therefore, we analyzed microtubule stability in fibroblasts derived from individuals with SMALED2, and in primary motor neurons that express the different BICD2 mutations. Furthermore, we established a Drosophila model for SMALED2, allowing in vivo analyses of tissue-specific effects of BICD2 mutations.
Results

Fibroblasts derived from individuals with SMALED2 display increased microtubule stability
To analyze the microtubule stability in fibroblasts derived from individuals with SMALED2, and control individuals without SMALED2, we performed depolymerization assays using cold treatment. At low temperatures, microtubules depolymerize releasing ab-tubulin dimers (21 Fig. S1A ), changes to microtubule depolymerization were observed after 60 min at 4 C (Fig. 1) .
Therefore, we measured the length of all remaining microtubules at this point (Fig. 1B) . Since no difference in microtubule stability was observed between three different control cell lines (Supplementary Material, Fig. S1B ), all further experiments were performed with one control cell line as reference. The majority of the control cells (81%) (Fig. 1C ) contained primarily very short microtubules (11.8 mm long in average) (Fig. 1B) . This shortening in microtubule length corresponds to the increased depolymerization rate upon cold conditions. Although only 19% of the control cells showed longer microtubules (>30 mm), a significant increase in the number of cells with long microtubules, was observed in all the SMALED2 lines (53% Ser107Leu, 55% Asn188Thr, 61% Thr703Met and 44% Arg747Cys) ( Fig. 1C and E) . The remaining microtubules were further stained with acetylated a-tubulin, a marker of stable microtubules (22) (Fig. 1A) .
Although the majority of the remaining microtubules per cell in the control line were non-acetylated and stained only with a-tubulin, a significant increase in acetylated microtubules was observed in each mutant line (Fig. 1D ). Our data suggests that BICD2 mutations cause an increased microtubule stability, as shown by an increased number of acetylated long microtubules upon cold treatment in comparison with control.
BICD2 mutations increase microtubule stability in motor neurons
Next, we investigated whether the increased microtubule stability observed in fibroblasts derived from individuals with SMALED2, is also observed in motor neurons, the most frequently reported cell type to be affected in SMALED2 (7, 23) . Primary motor neurons isolated from murine wild type (WT) embryos at E13.5, were transduced with lentivirus expressing WT-[BICD2-turbo GFP (tGFP)] or mutant BICD2-tGFP. After 7 days in vitro (DIV), the motor neurons were incubated with 30 mM nocodazole to induce depolymerization. The cells were fixed at different time points (30, 60, 90 and 120 min), and co-immunostained with antibodies against Choline acetyltransferase (ChAT), a common motor neuron marker (24) , and acetylated a-tubulin to visualize stable microtubules ( Fig. 2A and Supplementary Material, Fig. S2A ). For quantitative assessment of changes in microtubule stability, the mean fluorescence intensity of acetylated a-tubulin in the treated motor neurons with nocodazole and with the vehicle (mock) was measured, and expressed as a relative fluorescence to the mock ( Fig. 2B and Supplementary Material, Fig. S2B ). After 30 min of nocodazole treatment, the relative intensity of acetylated a-tubulin showed a similar decrease (57.2%) in non-transduced and in WT-BICD2 transduced (59.1%) motor neurons. In contrast, the motor neurons expressing the different mutant BICD2 showed only a mild or no decrease in the relative intensity of acetylated a-tubulin (85.5% Ser107Leu, 83.8% Asn188Thr, 84.2% Thr703Met and 104.5% Arg747Cys) (Fig. 2B) . At 60 and 90 min of treatment, there were no significant changes, with exception of the mutants Ser107Leu and Arg747Cys that still displayed higher Fig. S2B ). After 120 min, more than 50% of the initial acetylated a-tubulin intensity was decreased in non-transduced (37.3%) and WT-BICD2 transduced (41.1%) motor neurons (Fig. 2B) , while in the mutant transduced motor neurons, the drop in intensity was significantly less (57.7% Ser107Leu, 53.0% Asn188Thr, 63.2% Thr703Met and 57.9% Arg747Cys).
In this experiment, in the case of the non-transduced and WT-BICD2 transduced motor neurons, we were able to observe likely two different depolymerization phases, also referred by other groups as 'waves of depolymerization' (25) . These 'waves' may correspond to the depolymerization of differently stable microtubules along the axon (26, 27) . A first wave at 30 min (depolymerization of the highly labile and drug responsible microtubules at the axonal tip), and a second wave at 120 min (depolymerization of the stabile microtubules at the axon base). Our results indicate that in the presence of mutant BICD2, these two waves are not observed, the microtubule depolymerization is delayed, and the microtubules remain stable for longer time.
BICD2 mutations cause axonal defects in motor neurons
Microtubule dynamics plays an important role in axon growth and neuronal morphology (28) (29) (30) (31) . To analyze whether changes in microtubule stability affects axonal morphology, nontransduced and transduced motor neurons were immunostained at 7 DIV. Two neuronal markers were used, Tau to visualize axon and Microtubule-associated protein 2 (MAP2) to label dendrites (32) (Fig. 3A) . Two morphological parameters were evaluated, the length of the main axon (the longest) and the presence of branching. While no significant differences were found in WT-BICD2 transduced and non-transduced motor neurons, the motor neurons expressing the Thr703Met and Arg747Cys mutant proteins presented extremely long axons (Fig. 3B ). This increase was of 2.1-fold in Thr703Met versus nontransduced, 1.8-fold Thr703Met versus WT-BICD2 transduced, 1.9-fold Arg747Cys versus non-transduced, and 1.7-fold Arg747Cys versus WT-BICD2 transduced. The other two mutations, Ser107Leu and Asn188Thr, did not show significant differences in axonal length in comparison with non-transduced or WT-transduced motor neurons. Besides axonal length, we investigated the presence of any other alteration in the axonal morphology. Although the majority (68%) of axons of the nontransduced and (74%) of WT-BICD2 transduced motor neurons did not branch, axons without branches represented the minority for neurons expressing Ser107Leu (39%), Asn188Thr (32%), Thr703Met (29%) and Arg747Cys (23%) (Fig. 3C) . The mutants Ser107Leu, Thr703Met and Arg747Cys frequently displayed one long branch, while Asn188Thr often presented two or more long branches. The mutant Thr703Met and Arg747Cys showed curled motor neurons, likely due to their extreme long axons. Thus, motor neurons overexpressing SMALED2-causing BICD2 mutations develop axonal aberrations such as collateral long branching and overgrowth.
Generation and validation of Drosophila as a model system to investigate in vivo effects of BICD2 mutations
To study the consequences of BICD2 mutations in vivo, we generated D. melanogaster models for SMALED2.
Based on the mutation frequency and disease severity, we studied two SMALED2-causing mutations, Ser107Leu and Thr703Met, of the four mutations that we previously described in (3, 4) . Individuals with SMALED2 carrying either of the two mutations presented symptoms at birth or in early childhood. Moreover, all the affected individuals reported in our previous study, were born with foot deformities and joint contractures (muscle shortening), possibly due to a decreased intrauterine movement (4) . Importantly, Ser107Leu is the most frequently identified mutation in individuals with SMALED2, and it is considered as a hotspot mutation (7, 23) .
As the same two mutations were also identified in individuals who presented chronic myopathy, where muscles were primarily affected while the motor neurons were normal or presented only minor changes (33), we addressed the question whether these mutations affect primarily motor neurons or muscles.
To this end, we made use of the Galactose-induced genesustream activation sequence (GAL4-UAS) system in D. melanogaster, which facilitates the expression of genes of interest in a tissue-specific manner (34) . The fly BicD gene encodes a protein of 782 amino acids that is slightly shorter compared with its human counterpart which is 855 amino acids long. The two human mutations p.BICD2Ser107Leu and p.BICD2Thr703Met correspond to p.BicDSer103Leu and p.BicDThr644Met in the fly BicD protein respectively, and were engineered by site-directed mutagenesis of the fly BicD cDNA. The transgenic lines carrying either the WT or the mutated UAS-based BicD transgenes (UASBicD xx : WT; Ser103Leu; Thr644Met) were generated by /C31 integrase-mediated transgenesis. This technique allows the insertion of the transgenes into the specific chromosomal location within the genome (35) . We selected attP40 landing site on the 2L chromosome, which is 12 cM upstream of the endogenous BicD locus ( Neuronal-specific expression of BICD2 mutations cause locomotion impairment and defects in neuromuscular junction development in D. melanogaster
To determine the impact of the tissue-specific expression of Ser103Leu and Thr644Met mutations, we targeted the UASBicD xx transgenes either in neuronal tissue using the Synaptobrevin-GAL4 (nSyb-GAL4) driver line (36) (Supplementary regions corresponding to the marker areas in higher magnification. Scale bar ¼ 10 mm. The right panel shows the remaining microtubules after cold treatment stained with acetylated a-tubulin. (B) Quantification of the remaining microtubules after cold treatment. Data from three independent experiments (n ¼ 70 cells per line). Each dot represents microtubule length and the bars the mean 6 SD of each group. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA, followed by Dunnet's multiple comparison test to control. (C) Percentage of cells that still contain long microtubules (30 mm) upon cold treatment. The bars show the mean 6 SD of each group. *P < 0.05, **P < 0.01, ***P < 0.001, two-way ANOVA, followed by Dunnet's multiple comparison test to control. (D) Quantification of acetylated and non-acetylated microtubules per cell after cold treatment. The bars show the mean 6 SD of each group. *P < 0.05, **P < 0.01, ***P < 0.001, two-way ANOVA, followed by Dunnet's multiple comparison test to control. (E) Scheme of mutation position on BICD2 and percentage of cells with stable microtubules after cold treatment. BICD2-tGFP lentivirus, were treated at DIV7 with 30 mM nocodazole at different time points. The same amount of DMSO (7.5%) that was used to solve the nocodazole, was added to the medium as mock for the longest time point (120 min). The cells are stained using antibody against acetylated a-tubulin and ChAT as motor neuronal marker. (B) Relative fluorescence of the acetylated a-tubulin intensity from the axons to the average intensity of the mock. The quantification includes two independent experiments for each mutant. In each experiment the non-transduced and transduced WT-BICD2 motor neurons were included as controls. The bars show mean Material, Fig. S4A ), or in muscles using the Myocyte enhancer factor-2-GAL4 (Mef2-GAL4) line (37) (Supplementary Material,  Fig. S4B ). As controls we used progeny resulting from crossing the BicD heterozygotes (control) and the recombinant line expressing the transgenic WT BicD to the respective GAL4 driver lines. Importantly, the Western blot analysis confirmed that the different BicD xx transgenes were induced to similar levels ( Fig. 5A) and the overexpression of neither of the BicD xx transgenic proteins significantly impacted viability or adult eclosion rate.
As locomotion is impaired in individuals with SMALED2, we compared the climbing ability of D. melanogaster adults among the different genotypes, using the established negative geotaxis climbing assay, which is widely applied in neurodegenerative studies (38) . When targeting the expression into neuronal tissue, the locomotion of the recombinant line expressing the WT BicD was comparable to the control line (Fig. 5B) . In contrast, neuronal expression of either Ser103Leu or Thr644Met, caused locomotion defects ( Fig. 5B and Supplementary Material, Movie S1 and S2). The number of flies staying in the lower part of the cylinder, and failing to reach the top was markedly increased for both BicD mutants when compared with the control and the recombinant WT line. Importantly, no climbing defects were observed in flies, which overexpressed the BicD mutations in neuronal tissue in the presence of both WT BicD alleles (Supplementary Material, Fig. S5 ), suggesting a dominant negative rather than a gain of function effect of the BICD2 mutations. However, further molecular studies of the BicD function are required to discern between the two scenarios.
Furthermore, the muscle-specific expression of the BicD mutations in the heterozygous model, using Mef2-GAL4 did not Each dot represents length of the longest axon per motor neuron and the bars the mean 6 SD of each group. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA, followed impair the climbing ability (Fig. 5C) . Instead, all UAS-BicD xx containing lines showed a moderate increase in climbing activity compared with control ( Fig. 5C , zone 5). Previous studies in D. melanogaster showed that BicD is required during the nervous system development for the proper formation of the axonal termini at the neuromuscular junctions (NMJs), via a modulation of trafficking processes at the synapse (39) . Given the locomotion phenotype of the SMALED2 flies and the importance of BicD for the synapse development (39), we analyzed the NMJs in the recombinant D. melanogaster lines crossed with the neuronal nSyb-GAL4 driver. We focused on the NMJs innervating the muscles 6/7, as these are considered ideal for studying NMJ growth and expansion, because they are the longest and innervate two muscles (40) . The NMJs were stained using a presynaptic marker horseradish peroxidase (HRP) and a postsynaptic marker Discs large 1 (Dlg1) (Fig. 5D) . The total area of the NMJ (including presynapse and postsynapse) was quantified ( Fig. 5E and Supplementary Material, Fig. S6 ). While no differences were observed between control and recombinant WT BicD fly, the size of the NMJs significantly decreased in recombinant larvae expressing the two mutant BicD proteins ( Fig. 5D and E), indicating plausible defects in growth and/or expansion.
Taken together, these results demonstrate that both SMALED2-causing BICD2 mutations interfere with a proper development of NMJs and have a detrimental effect on fly locomotion when overexpressed in neurons but not in muscles.
Discussion
BICD2 mutations increase microtubule stability and cause pathological defects at axonal and NMJ level This study shows that fibroblasts derived from individuals with SMALED2, exhibit markedly longer and more stable microtubules than control under cold treatment. This phenotype arises regardless of where the mutation in BICD2 is located, indicating a shared pathomechanism among mutations. Motor neurons overexpressing SMALED2-causing BICD2 mutations, show increased microtubule stability and develop axonal aberrations such as collateral long branching and overgrowth.
Previous studies had described that the microtubule stability is increased in developing axons, and plays a direct role in polarization, morphology and guidance of the axon (41, 42) . Moreover, an increase in microtubule stability causes the formation of multiple long axonal branches (also called collateral axons) (42) , which goes in line with our obtained results. The deleterious consequences of increased long axonal branches in motor neurons have been widely discussed in axonal regeneration studies, pointing that these axonal branches are often 'misrouted' and fail to efficiently innervate the targeted muscle leading to weakness and atrophy (43) (44) (45) (46) .
Recently, Huynh and Vale reported that the overexpression of BICD2 Ser107Leu mutant in hippocampal neurons showed no difference in neurite length (by measuring the longest neurite) in comparison with control, which is comparable to our results (47) . Instead, the Asn188Thr mutant showed a decrease in neurite length while we observed no difference in comparison with control. It is likely that this difference is due to different type of neurons studied (hippocampal versus motor neurons), different DNA delivery technique (Lipofectamine versus transduction), and different duration of culture (3 versus 7 DIV). It is important to note, that in individuals with SMALED2 motor neurons but not hippocampal neurons have been reported to be affected, and these individuals do not present clinical manifestations compatible to affections in the hippocampus but rather spinal muscular atrophy (1,2,4,7,23).
The underlying molecular mechanism that links BICD2 mutations to microtubule stability and axonal branching may involve the role of BICD2 in the regulation of dynein, dynactin (48, 49) and kinesin (50) . Previous studies reported that these motor proteins directly participate in the regulation of microtubule dynamics and assembly (51) . For example, cytoplasmic dynein is required for the proper alignment of microtubules in the axon (52) . Furthermore, the large subunit of dynactin, p150
Glued can suppress total microtubule catastrophe (increase shortening state or depolymerization) (53, 54) , and the microtubule depolymerases that belong to the kinesin family, regulate microtubule disassembly (55, 56) . Interestingly, neurons depleted of kinesin-5 exhibit much longer axons with increased branching (57) . Congruent with previous studies (1,2) and our results (Supplementary Material, Fig. S7 ), mutations in BICD2 alter the interaction with the dynein-dynactin complex. Aberrant interactions might change the ability of BICD2 to regulate the dynein-dynactin complex. This regulation of the dyneindynactin complex is important not only for processivity but also for the stabilization of the complex as previously reported in (8) . Even though the impact of BICD2 mutations on kinesin interaction and/or regulation has not been investigated, we cannot rule out this possibility. Moreover, recent studies show that dynein-dynactin and kinesin are opponents in a tug-war competition along microtubules, and BICD2 has a key role in shifting the balance of forces between dynein and kinesin motors (49). ative to muscle area (n 4 larvae per genotype, one to two NMJs per larva). The bars show the mean 6 SD *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA, followed by Dunnet's multiple comparison test to control (background without transgene crossed with driver).
The correct regulation of both complexes has been suggested to facilitate the transport of cargo along the microtubules as well as the correct microtubule assembly during axonal development (13) . In addition to axonal development, motor proteins and microtubules are important in the development of the NMJ (58, 59) . Studies in D. melanogaster have shown that presynaptic microtubules undergo a dynamic reorganization to assure the correct development of these large NMJs (58). It has been described that D. melanogaster BicD is needed for the correct development of NMJ by controlling the synaptic vesicle recycling (39) . We found that the BICD2 mutations cause aberrations in the NMJ development which might be caused either by problems in the dynein transport at the synapse, microtubule impairment or both.
Are BICD2 mutations neuronal or muscle specific?
Previously, the clinical evaluation of the affected individuals carrying the Ser107Leu and Thr703Met mutations in BICD2, revealed evident neurogenic changes as the cause of the pathology (60, 61) . Recently, we have reported two new families carrying the same mutations in BICD2, but instead of a primary neurogenic disorder, the affected individuals showed predominant chronic myopathic alterations and minor neurogenic changes (33) .
Our D. melanogaster model showed that these mutations cause locomotion impairment, when expressed in neuronal tissue of the heterozygous BicD flies, while their muscle-specific expression had no such effect. This indicates that the impact of SMALED2-causing BICD2 mutations on locomotion is primarily motor neuron-specific. We cannot, however, exclude that the neuronal effect arises due to a higher efficacy of the nSyb-GAL4 driver line. Additionally, analysis of the BICD2 level in mouse showed high expression in the muscles reported as affected in individuals with SMALED2 (Supplementary Material, Fig. S8) . Interestingly, the BICD2 expression in muscle evidently increased over time in gastrocnemius, the most commonly reported affected muscle, while the expression in spinal cord decreases (Supplementary Material, Fig. S9 ). For all these reasons, we cannot rule out the muscular contribution to the disease in more complex organisms.
The mutation Thr703Met (Thr644Met in D. melanogaster) is pathogenic Interestingly, we recently described a very mildly affected mother, carrying the same Thr703Met mutation as her affected son (62) . The very same mutation was previously described as causative of a SMALED2 with congenital symptoms (4). Our in vitro and in vivo studies confirmed that indeed this mutation causes pathological changes at the NMJ level and impaired locomotion. These findings strongly suggest that other factors such as genetic modifiers may protect some unaffected individuals against SMALED2 as nicely shown for 5q-SMA (63, 64) . We believe this is an important point to consider when identifying mutations like the Thr703Met in BICD2 during genetic screening.
Taken together, we identified a common pathomechanism of BICD2 mutations causing increased microtubule stability in motor neurons. We propose that this increased microtubule stability contributes considerably to aberrations in the axonal and NMJ morphology, but we cannot rule out that this effect might be downstream of other processes. The presentation and severity of SMALED2 may be defined by specific effects of the mutations, such as Golgi fragmentation (4), changes on dynein interaction (1,2), dynein-dynactin motility, and cargo transport (47) . Moreover, by generating an in vivo SMALED2 model we found that BICD2 mutations affect primarily motor neurons and lead to impairment in locomotion similar to individuals with SMALED2.
Materials and Methods
Fibroblast culture and cold-induced depolymerization
Fibroblast cells were grown as adherent monolayer cultures in DMEM medium, at 37 C in a humid atmosphere containing 5% CO 2 . The cells were washed once with PBS and then trypsinized using Trypsin-EDTA. After counting in a Neubauer chamber, 25 000 cells were plated per well (24-well plate) previously coated with gelatin. Four wells per plate were used for each cell line (four mutants and one control). Five identical 24-well plates were prepared per experiment. Next day, one 24-well plate was kept at 37 C and the others were placed at 4 C during different time points to induce microtubule depolymerization. Upon incubation, the cells were fixed in 4% paraformaldehyde (PFA) solution for 15 min at room temperature and immunostained following the corresponding protocol.
Ethics statement
All procedures involving laboratory animals were performed according to the German laws of animal welfare and were approved by the 'Landesamt fuer Natur, Umwelt und Verbraucherschutz NRW' under the reference number 84-02.04.2014.A126.
Primary murine motor neuron culture
Cultures of spinal motor neurons were prepared from embryonic day 13.5-WT C57BL/6J mice. Briefly, the spinal cords were dissected from embryos at E13.5 and incubated in Trypsin (1: 20 in PBS). After centrifugation at 1000g and 4 C for 5 min, the trypsin was removed and DNaseI (1:20 in plating Medium) was added. The tissue was carefully pipetted up and down until it was dissolved. The motor neurons were plated in plating medium (DMEM 91%, fetal bovine serum 5%, penicillin/streptomycin 1%, glucose 0.6% and Amphotericin B 0.25%) on coverslips previously coated with poly-D-lysine (Sigma-Aldrich).
Cloning of vectors for lentiviral transduction and virus production
The WT type and mutant BICD2 cDNAs (NM_001003800.1) initially inserted into pCMV6 vectors (4), were recloned using enzymatic restriction, into a pSIN-EF2-Nanog-Pur vector (Addgene). The vectors were produced in large scale and purified using the EndoFree Plasmid Maxi Kit (Qiagen, 1362) according to the manufacturer's instructions. To produce the virus particles, HEK293T cells were transfected with second generation packaging vectors PMD (3 mg) and pPAX (5 mg) (Addgene) and the BICD2-tGFP plasmid (10 mg) (pSIN-EF2-Nanog-Pur, Addgene) using calcium chloride precipitation. The medium was changed 7 h after transfection and the first batch of virus was collected 24 h after transfection, followed by second collection at 36 h.
Transduction and microtubule depolymerization experiment in murine motor neurons
At 1 DIV primary motor neurons were infected with 1:5 ratio of the virus pool for 6 h. The cells were washed once with NB medium (Thermo Fischer Scientific). The media was replaced with fresh NB/B27 medium supplemented with B27 supplement, L-glutamine, penicillinin/streptomycin, amphotericin B, and with additional growth factors cilliary neurotrophic factor (CNTF, 50 ng/ml), brain-derived neurotrophic factor (BDNF, 50 ng/ml) and glial cell-line derived neurotrophic factor (GDNF, 50 ng/ml) (Prepotech). The cells were incubated at 37 C in 5% CO 2 for 6 days. We proceeded with the depolymerization experiments using very similar conditions as in (65) . The motor neurons were treated with 30 mM nocodazole (Sigma), which was dissolved in DMSO and added to the NB medium and incubated during different time points (30, 60 , 90 and 120 min). As mock, the same concentration of DMSO without nocodazole was added to the medium. After the incubation time was over, the NB medium was removed and the cells were washed with PBS for 5 min.
Immunostaining of fibroblasts and murine motor neurons
Immunostaining of fibroblasts: After removal of the PFA, the cells were washed twice with PBS-Glycine (containing 30 mM Glycine) for 3 min. PBS (containing 0.5% Triton X-100) was added for 10 min for permeabilization, followed by two washes with PBS-Glycine for 3 min. 
Fly generation and stocks
The following fly strains were used: w; Mef2.R-GAL4/TM6B (BL27390), w; UAS-2xEGFP (BL6874), w; UAS-mCD8-mCherry (BL27391) from the Bloomington D. melanogaster Stock Center. The w, BicD r5 /CyO and and w; nSyb-GAL4 fly lines were kindly provided by Prof Beat Suter (6) 
Western blots of fly proteins
The whole flies (10 for each line) were lyzed in RIPA buffer (Sigma-Aldrich) with protease inhibitors (Sigma-Aldrich) using Precellys homogenizer (Peqlab Biotechnologie). The supernatant was collected in a new tube. The samples (7 mg of protein) were separated by 12% SDS-PAGE gel, transferred to a PVDF membrane and probed with the anti-FLAG antibody (Sigma-Aldrich, F1804) and anti-a Spectrin (Developmental Studies Hybridoma Bank, 3A9) antibodies.
Locomotion experiments
For climbing assays, thirty 10 day-old male flies were placed in a 100-ml glass measuring cylinder fitted with a cotton plug on top. The cylinder was divided into five regions with region five being at the top and one at the bottom, as previously described in (67) . Each experiment was blinded and recorded using a high definition video camera (Panasonic, HC-V250) placed 30 cm from the cylinders. The cylinders were knocked on a soft surface to force flies to the bottom. Flies were then given 12 s to climb towards the top of the column. Each assay was repeated three times. The videos were analyzed by counting the flies in each zone of the cylinder at the end of the time. The number of flies found in each zone was divided by the total number of flies that were counted. For each genotype, a minimum of 60 flies was tested.
Dissection and immunohistochemistry of fly NMJs
For the fly NMJs, third instar larvae were dissected in HL3 buffer (containing 110 mM NaCl, 5 mM KCl, 10 mM NaHCO 3 , 5 mM HEPES, 30 mM Sucrose, 5 mM Trehalose, 10 mM MgCl 2 , 1 mM CaCl 2 ) on a sylgard plate as previously described in (68) . The tissue was fixed with 3.7% paraformaldehyde in HL3 for 20 min at room temperature. After fixation, the samples were washed 
Image acquisition and analysis
Confocal images of human fibroblasts and fly NMJs were obtained by an Olympus Fluoview FV1000. Motor neurons were imaged using the confocal microscope Leica SP8 equipped with HyD detector. High resolution images were analyzed by ImageJ (Fiji) software and processed in Photoshop. For axon length quantification and depolymerization experiments in motor neurons (double-blind), immunofluorescent images were obtained with the same settings using a Zeiss microscope (Axio Imager.M2).
For quantification of the cold-induced depolymerized microtubules in fibroblasts, the length of all the remaining microtubules was measured using the ImageJ (Fiji) software. The term 'long microtubule' was defined as longer as 30mm, which corresponds to the double of the length average of the microtubules observed in the control. The number of cells that still presented long microtubules was counted manually.
For the microtubule depolymerization studies in motor neurons, the acetylated microtubules were analyzed using the ImageJ (Fiji) software on a macro setting and the Li threshold method was applied to delineate the areas of the axons exclusively. The mean intensity of the staining for acetylated a-tubulin was measured for each time point of the experiment and related to the mean intensity obtained for the mock situation, as described in (69) . For the quantification of the axonal length, the longest axon of each neuron was traced manually using ImageJ (Fiji). The additional long branches were counted manually, similar to (70) . A long branch was defined as more than three times the radius of the cell body.
For the fly NMJ area, the measurements were obtained by outlining the presynapse (HRP signal) and the postsynapse (Dlg1 signal) areas using the ImageJ (Fiji) software (71) , and this measurement was normalized to the corresponding muscle area, as shown in (72) .
Statistical analyses
One-and two-way (when applicable) ANOVA tests, followed by Dunnet's multiple comparison, and Pearson chi-squared test were used. Statistical analyses were performed using GraphPad Prism version 6.0d.
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